1-3 of 3
Xiaojun Qian
Close
Sort by
Journal Articles

CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results

Clinical Trials & Observations
Brian G. Till, Michael C. Jensen, Jinjuan Wang, Xiaojun Qian, Ajay K. Gopal, David G. Maloney, Catherine G. Lindgren, Yukang Lin, John M. Pagel, Lihua E. Budde, Andrew Raubitschek, Stephen J. Forman, Philip D. Greenberg, Stanley R. Riddell, Oliver W. Press
Journal: Blood
Blood (2012) 119 (17): 3940–3950.
https://doi.org/10.1182/blood-2011-10-387969
Published: 2012
Includes: Supplemental data
Journal Articles

Phase I Trial Results Testing Adoptively Transferred T Cells Expressing CD20-Specific Chimeric Antigen Receptors Containing CD28 and CD137 Costimulatory Domains In Patients with Mantle Cell Lymphoma and Indolent Lymphoma

Brian G. Till, MD, Michael C. Jensen, MD, Xiaojun Qian, Jinjuan Wang, Ajay K Gopal, MD, David G. Maloney, Catherine G. Lindgren, Yukang Lin, John M. Pagel, MD, PhD, Lihua E Budde, MD., PhD, Andrew Raubitschek, MD, Stephen Forman, Philip Greenberg, Stanley R. Riddell, MD, Oliver W. Press, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 561.
https://doi.org/10.1182/blood.V116.21.561.561
Published: 2010
Journal Articles

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

Clinical Trials & Observations
Brian G. Till, Michael C. Jensen, Jinjuan Wang, Eric Y. Chen, Brent L. Wood, Harvey A. Greisman, Xiaojun Qian, Scott E. James, Andrew Raubitschek, Stephen J. Forman, Ajay K. Gopal, John M. Pagel, Catherine G. Lindgren, Philip D. Greenberg, Stanley R. Riddell, Oliver W. Press
Journal: Blood
Blood (2008) 112 (6): 2261–2271.
https://doi.org/10.1182/blood-2007-12-128843
Published: 2008
Includes: Supplemental data